InvestorsHub Logo
Followers 103
Posts 4897
Boards Moderated 0
Alias Born 10/06/2011

Re: None

Friday, 06/11/2021 2:05:56 PM

Friday, June 11, 2021 2:05:56 PM

Post# of 413767
I have been busy and little inclined to post or respond to posts directed my way. Yes, I will provide ELTP a list of questions, observations, and suggestions. Yes, I will get around to offer a perspective on what they are worth...but think it wise to wait to see what the numbers look FY 2021. I think it a fools errand to guess what their numbers will be because the full weight of the pandemic seems beyond the reach or grasp of investors, who look at the prorated market share portion of Elite's commercialized products and think that is an easy capture. It is not. And the impact of the pandemic is little understood because of myriad reasons. So, what is the reality? Why not ask Elite's most important partner LCI? Of course, this is a metaphorical ask...but if seeking an answer, it is there amidst LCI's most recent quarterly report...page 8 https://seekingalpha.com/filings/pdf/14931880

While COVID-19 has thus far not had a material impact on the Company’s operations, subsequent to an initial stocking up of supplies at the start of the pandemic, the total volume of drug prescriptions being written in the country has decreased causing less demand for our products. We cannot reasonably predict the ultimate impact of COVID-19 on our future results of operations and cash flows due to the continued uncertainty around the duration and severity of the pandemic.



LCI's problems are Elite's problems.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News